SCHEMBL13488135

SCHEMBL13488135

CC1(C)c2ccccc2-c2ccc(-c3ccc4c(-c5cnc6ccccc6n5)c5ccccc5c(-c5ccc6c(c5)C(C)(C)c5ccccc5-6)c4c3)cc21

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 11/20 0.40
MAPT P10636 5/20 0.38
ALDH1A1 P00352 3/20 0.38
KMT2A Q03164 2/20 0.38
MEN1 O00255 1/20 0.38
ALOX12 P18054 1/20 0.38
MAPK10 P53779 1/20 0.38
ATM Q13315 1/20 0.38
RAB9A P51151 9/20 0.36
SMN1; SMN2 Q16637 5/20 0.36
BCHE P06276 1/20 0.36
KDM4E B2RXH2 2/20 0.36
HPGD P15428 2/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
JAK2 O60674 1/20 0.34
ADORA3 P0DMS8 1/20 0.33
ADORA1 P30542 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
PDGFRB P09619 1/20 0.33
KDR P35968 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13487905 0.97 NPC1 (0.38) NPC1MAPTALDH1A1KMT2AMEN1
SCHEMBL13487773 0.97 NPC1 (0.38) NPC1MAPTALDH1A1KMT2AMEN1
SCHEMBL13488059 0.95 NPC1 (0.36) NPC1MAPTALDH1A1KMT2AMEN1
SCHEMBL13487984 0.93 NPC1 (0.36) NPC1MAPTALDH1A1KMT2AMEN1
SCHEMBL13487834 0.93 NPC1 (0.40) NPC1MAPTALDH1A1KMT2AMEN1
SCHEMBL13487519 0.92 NPC1 (0.37) NPC1MAPTALDH1A1KMT2AMEN1
SCHEMBL13487371 0.92 NPC1 (0.37) NPC1MAPTALDH1A1KMT2AMEN1
SCHEMBL13158891 0.91 NPC1 (0.38) NPC1MAPTALDH1A1RAB9ASMN1; SMN2
SCHEMBL13487668 0.90 NPC1 (0.36) NPC1MAPTALDH1A1KMT2AMEN1
SCHEMBL13651087 0.88 NPC1 (0.34) NPC1MAPTALDH1A1KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100045170-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-25 US disclosed
US-20100045170-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100045170-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same OCIAD1, OCIAD2, ORMDL3 NPC1 1139/4885MAPT 2219/4885ALDH1A1 101/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.